Focus box
Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
Seattle-based pre-clinical biotech Umoja Biopharma aims to revolutionise immunotherapy by retooling the patient’s immune system in vivo. Based on the…
Breast cancer research: addressing the premenopausal problem
Although the risk of breast cancer increases with age, the disease can affect young patients too. More than 16,000 American…
Head-to-head: competition heats up as new HIV prevention drug shows promise
Once a certain death sentence, HIV infection has now become a manageable condition. This is due to the introduction of…
Precision medicine in AMD: SPAC merger sees Gemini make its public debut
Precision medicine-focused Gemini Therapeutics has completed a business combination transaction with Foresite Capital’s special purpose acquisition company (SPAC) FS Development…
How a sleeping drug awakened a patient with akinetic mutism
One day a 29-year-old Dutch man called Richard choked on a piece of meat while out for dinner with friends.…